HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ICCR To Consider Regulatory Harmonization On Allergen Issues

This article was originally published in The Rose Sheet

Executive Summary

At FDA’s June 2 public meeting to prepare for the eighth iteration of the International Cooperation on Cosmetics Regulation, the agency recapped accomplishments from ICCR-7 and outlined cosmetic regulatory topics to be addressed at ICCR-8. Allergens are up for discussion, as are trace materials.

You may also be interested in...

ICCR Adds Cosmetic Product Preservation To Agenda For Ninth Meeting

During a public preparatory meeting in advance of the ninth International Cooperation for Cosmetics Regulation summit, FDA Office of Cosmetics and Colors Director Linda Katz said that the topic of cosmetic product preservation will be included on the agenda for the first time. Animal-testing alternatives, allergens and trace impurities also are up for discussion, continuing regulators' work from last year on those topics.

ICCR Will Have Growing Role In Setting Global Policy – Industry Groups

Following the International Cooperation on Cosmetics Regulation’s eighth meeting in Ottawa, representatives from trade groups PCPC and CCTFA spoke with “The Rose Sheet” about ICCR’s progress to date and its growing influence on regulation within core member jurisdictions, as well as with other stakeholders around the world.

In Brief

ICCR’s new centralized website provides access to documents on topics of interest and other information on the coalition. More news in brief.

Related Content




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts